june
world
health
organ
signal
novel
flu
pandem
underway
viru
triplereassort
influenza
viru
contain
gene
human
swine
avian
influenza
virus
case
control
studi
patient
select
influenza
special
clinic
emerg
flu
depart
accord
attend
control
group
patient
flu
symptom
sign
neg
serolog
test
patient
infect
present
flulik
symptom
benign
cours
patient
comorbid
may
seriou
clinic
present
hypoxemia
main
caus
death
acut
respiratori
distress
syndrom
ard
first
case
influenza
viru
infect
area
thrace
greec
document
univers
hospit
alexandroupoli
august
purpos
studi
investig
potenti
differ
admiss
posit
neg
patient
flulik
symptom
univers
hospit
alexandroupoli
report
center
viru
region
thrace
greec
hospit
consist
fifti
depart
one
unit
infecti
diseas
influenza
epidem
special
depart
flu
establish
patient
flu
symptom
andor
sign
refer
patient
posit
flu
test
transfer
bed
unit
neg
pressur
especi
design
quarantin
isol
patient
airborn
transmit
viral
infect
august
decemb
case
confirm
influenza
viru
hospit
quarantin
unit
infecti
diseas
patient
flulik
symptom
sore
throat
cough
rhino
rhea
nasal
congest
fever
admit
unit
infecti
diseas
gave
pharyng
nasopharyng
swab
swab
test
realtim
reversetranscriptasepolymerasechainreact
rtpcr
previou
report
studi
also
mention
although
rtpcr
sensit
specif
test
diagnosi
influenza
viru
infect
upper
respiratori
tract
specimen
specif
lower
respiratori
tract
specimen
result
given
period
time
hour
patient
remain
quarantin
isol
neg
pressur
chamber
accord
guidelin
depart
prefer
use
pneumonia
sever
index
order
evalu
sever
diseas
howev
score
differ
two
group
pneumonia
score
index
calcul
patient
group
class
rang
iiiv
repeat
hini
test
day
admiss
patient
neg
initi
test
becam
posit
total
patient
admit
four
month
period
posit
group
neg
group
b
posit
patient
remain
quarantin
isol
neg
patient
move
depart
intern
medicin
patient
monitor
discharg
symptom
sign
record
daili
return
normal
bodi
temperatur
defin
temperatur
less
day
withdraw
antipyret
treatment
criteria
discharg
absenc
hypoxemia
normal
chest
xray
temperatur
day
without
antipyret
treatment
upon
admiss
procalcitonin
pct
evalu
perform
patient
group
group
b
nine
patient
exam
avail
due
lack
reagent
laboratori
also
urin
antigen
legionella
streptococcu
pneumonia
test
upon
admiss
patient
neg
upon
admiss
sputum
stain
given
patient
group
group
b
rest
patient
produc
enough
sputum
quantiti
stain
cooper
give
sputum
final
blood
cultur
collect
patient
bodi
temperatur
exceed
result
came
posit
continu
variabl
summar
mean
median
interquartil
rang
categor
variabl
percentag
patient
categori
calcul
unpair
test
use
normal
distribut
paramet
compar
mean
valu
paramet
two
group
p
valu
less
consid
indic
statist
signific
characterist
group
clinic
laboratori
paramet
compar
two
group
b
analys
carri
use
spss
statist
softwar
packag
spss
version
spss
chicago
il
usa
major
posit
patient
group
caucasian
male
mean
age
year
neg
patient
group
b
caucasian
male
mean
age
year
tabl
coexist
condit
present
patient
group
patient
group
b
asthma
vs
chronic
obstruct
diseas
vs
idiopath
pulmonari
fibrosi
vs
lymphoma
vs
diabet
vs
coronari
heart
diseas
vs
previou
report
studi
tabl
patient
group
group
b
acut
asthma
exacerb
none
femal
studi
pregnant
femal
patient
sexual
activ
group
neg
pregnanc
test
patient
treat
oseltamivir
regimen
mean
time
day
group
vs
day
group
b
patient
group
addit
treatment
azithromycinmoxifloxacin
ceftriaxon
ad
time
admiss
due
local
patchi
shadow
chest
xray
fever
patient
group
group
b
second
chest
film
posit
pneumonia
infiltr
patient
chest
xray
statu
upon
admiss
present
tabl
patient
group
sputum
cultur
receiv
pathognomon
isol
cfu
bacteria
achiev
streptococcu
pneumonia
speci
mycoplasma
speci
moraxella
catarrhali
hand
group
b
patient
pathognomon
isol
achiev
streptococcu
pneumonia
speci
mycoplasma
speci
group
b
patient
treat
doubl
antibiot
regimen
amoxicillinclavulan
acidazithromycin
ceftriaxonemoxifloxacinciprofloxacin
mean
time
hospit
day
empir
antibiot
treatment
ad
upon
admiss
base
elev
valu
crp
wbc
chest
xray
find
sinc
earli
antibiot
treatment
prevent
progress
diseas
marker
known
elev
infect
diseas
reiquelm
et
al
also
initi
earli
antivir
antibiot
treatment
order
prevent
progress
coinfect
clinic
statu
patient
studi
discharg
chest
radiograph
becam
normal
temperatur
day
seven
patient
group
patient
group
b
sever
hypoxemia
upon
admiss
mmhg
room
air
tabl
hypoxemia
defin
decreas
partial
pressur
oxygen
blood
mmhg
differ
two
group
smoke
n
vs
b
n
tabl
obes
observ
higher
patient
group
b
mean
small
number
group
mean
p
valu
tabl
accord
global
databas
bodi
mass
index
patient
consid
obes
bmi
leucopenia
grade
observ
patient
diagnos
lymphoma
group
tabl
group
b
patient
lymphoma
present
pneumonia
admiss
abnorm
liver
function
elev
level
serum
liver
enzym
bilirubin
found
patient
group
vs
patient
group
b
tabl
patient
treatment
moreov
platelet
abnorm
patient
two
group
creactiv
protein
crp
normal
laboratori
valu
mgdl
white
blood
count
wbc
elev
group
b
comparison
group
mean
vs
among
white
blood
count
wbc
subgroup
signific
differ
observ
white
blood
count
wbc
return
normal
patient
group
group
b
day
hospit
creactiv
protein
crp
return
normal
patient
group
group
b
also
patient
group
group
b
elev
level
serum
liver
enzym
bilirubin
return
normal
day
mention
none
patient
receiv
medic
affect
white
blood
count
wbc
eg
corticosteroid
tabl
none
patient
acut
renal
failur
none
patient
unit
infecti
diseas
intub
admit
icu
comparison
studi
also
patient
ask
vaccin
none
vaccin
even
season
influenza
differ
mean
satur
among
two
group
tabl
patient
group
hypoxemia
hospit
day
day
one
patient
recent
diagnos
idiopath
pulmonari
fibrosi
co
morbid
signific
differ
observ
mean
temperatur
satur
partial
two
group
tabl
describ
case
seri
sixti
patient
hospit
unit
infecti
diseas
august
decemb
flulik
symptom
test
rtpcr
viru
patient
posit
remain
neg
main
differ
two
group
correspond
clinic
messag
summar
underneath
case
control
studi
includ
patient
influenza
symptom
admit
emerg
flu
depart
accord
attend
limit
studi
includ
data
repres
experi
singl
center
procalcitonin
test
given
patient
also
erythrocyt
sediment
rate
esr
sporad
collect
follow
patient
evalu
bacteri
pneumonia
associ
influenza
consid
import
factor
lead
poor
patient
outcom
prior
pandem
even
though
none
blood
cultur
posit
unabl
evalu
effect
bacteri
coinfect
patient
outcom
sinc
blood
cultur
obtain
studi
popul
fever
workup
atyp
pathogen
perform
although
bacteri
coinfect
document
major
studi
popul
treat
antibiot
prior
public
fail
demonstr
signific
involv
bacteri
pathogen
hospit
patient
viru
pneumonia
initi
evalu
patient
group
b
group
antibiot
treatment
prescrib
gener
practition
none
patient
sputum
cultur
time
furthermor
receiv
cultiv
sputum
sampl
patient
suppos
fals
neg
cultur
pneumonia
patient
mainli
due
mix
microbi
flora
natur
colon
admixtur
upper
airway
subgroup
patient
pneumonia
group
small
statist
analysi
imposs
power
sampl
quit
small
futur
studi
necessari
defin
best
treatment
viru
pneumonia
role
combin
antivir
therapi
lack
signific
differ
percentag
patient
hypoxemia
two
group
probabl
due
proxim
number
patient
local
patchi
shadow
observ
group
b
group
tabl
obes
known
associ
influenza
viral
infect
cohort
observ
group
b
larger
number
obes
patient
opposit
group
vs
p
unabl
explain
reason
major
patient
obes
studi
previou
report
studi
obes
risk
factor
poor
outcom
patient
season
influenza
obes
suggest
risk
factor
poor
outcom
patient
influenza
infect
usa
case
control
studi
larg
number
patient
suffer
lymphoma
observ
patient
receiv
chemotherapi
regimen
make
vulner
respiratori
infect
patient
group
b
elev
creactiv
protein
mean
vs
white
blood
count
wbc
comparison
group
mean
vs
suggest
microbi
infect
alreadi
upon
admiss
elev
valu
creactiv
protein
wbc
known
associ
bacteri
infect
earli
antibiot
treatment
prevent
progress
diseas
report
previou
studi
symptom
oseltamivir
mainli
observ
group
nausea
vs
diarrhea
vs
vomit
vs
probabl
larger
dose
prolong
treatment
oseltamivir
vs
previous
report
howev
difficult
distinguish
pharmaceut
side
effect
osetalmivir
tamiflu
influenza
symptom
patient
receiv
antivir
treatment
less
day
oseltamivir
given
proof
neg
rtpcr
result
sinc
patient
posit
prevent
progress
diseas
shown
previou
observ
studi
moreov
mean
durat
hospit
stay
group
b
vs
day
group
time
need
normal
chest
radiograph
nevertheless
signific
differ
two
group
day
hospit
limit
due
earli
oseltamivir
group
antibiot
treatment
group
b
previous
explain
lastli
mean
young
age
patient
group
small
number
comorbid
observ
sampl
patient
possibl
also
respons
overal
mild
clinic
cours
patient
gener
mild
clinic
cours
none
patient
admit
icu
author
declar
compet
interest
pz
collect
analyz
data
wrote
manuscript
tk
analyz
data
provid
critic
insight
kz
np
ps
provid
interpret
data
final
version
manuscript
em
collect
interpret
data
provid
critic
insight
author
read
approv
final
version
manuscript
